Occupational Activity
Daiichi Sankyo Invests $1 Billion to Expand German Facility for Precision Cancer Antibody-Drug Conjugates
Daiichi, Sankyo, Antibody-Drug Conjugates
BioNTech Boosts CAR-T Manufacturing Prowess with Autolus Investment and mRNA Synergy
BioNTech, CAR-T, Manufacture, Investments, Autolus
Teva to offload API business as it concentrates on lead drug products
business career, Teva, API, lead drug products, offload, products
AbbVie pours $223M into building out its biologics capacity in Singapore
Biological Factors, expansion, AbbVie, Capacity, Investments, Manufacture, Singapore
Lonza closes plant in China but CDMO’s sales signal an uptick in industry
Plants, China, Signal, Industry, Congestive heart failure